Novo Nordisk must have liked what it saw in the first few months of its R&D tie-up with UK artificial intelligence company e-Therapeutics, as it has doubled down on the deal midway through.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,